Literature DB >> 12662897

Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project.

John C Lindon1, Jeremy K Nicholson, Elaine Holmes, Henrik Antti, Mary E Bollard, Hector Keun, Olaf Beckonert, Timothy M Ebbels, Michael D Reily, Donald Robertson, Gregory J Stevens, Peter Luke, Alan P Breau, Glenn H Cantor, Roy H Bible, Urs Niederhauser, Hans Senn, Goetz Schlotterbeck, Ulla G Sidelmann, Steen M Laursen, Adrienne Tymiak, Bruce D Car, Lois Lehman-McKeeman, Jean Marie Colet, Ali Loukaci, Craig Thomas.   

Abstract

The role that metabonomics has in the evaluation of xenobiotic toxicity studies is presented here together with a brief summary of published studies. To provide a comprehensive assessment of this approach, the Consortium for Metabonomic Toxicology (COMET) has been formed between six pharmaceutical companies and Imperial College of Science, Technology and Medicine (IC), London, UK. The objective of this group is to define methodologies and to apply metabonomic data generated using (1)H NMR spectroscopy of urine and blood serum for preclinical toxicological screening of candidate drugs. This is being achieved by generating databases of results for a wide range of model toxins which serve as the raw material for computer-based expert systems for toxicity prediction. The project progress on the generation of comprehensive metabonomic databases and multivariate statistical models for prediction of toxicity, initially for liver and kidney toxicity in the rat and mouse, is reported. Additionally, both the analytical and biological variation which might arise through the use of metabonomics has been evaluated. An evaluation of intersite NMR analytical reproducibility has revealed a high degree of robustness. Second, a detailed comparison has been made of the ability of the six companies to provide consistent urine and serum samples using a study of the toxicity of hydrazine at two doses in the male rat, this study showing a high degree of consistency between samples from the various companies in terms of spectral patterns and biochemical composition. Differences between samples from the various companies were small compared to the biochemical effects of the toxin. A metabonomic model has been constructed for urine from control rats, enabling identification of outlier samples and the metabolic reasons for the deviation. Building on this success, and with the completion of studies on approximately 80 model toxins, first expert systems for prediction of liver and kidney toxicity have been generated.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12662897     DOI: 10.1016/s0041-008x(02)00079-0

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  33 in total

Review 1.  Metabolic profiles to define the genome: can we hear the phenotypes?

Authors:  Julian L Griffin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2004-06-29       Impact factor: 6.237

2.  Global urinary metabolic profiling procedures using gas chromatography-mass spectrometry.

Authors:  Eric Chun Yong Chan; Kishore Kumar Pasikanti; Jeremy K Nicholson
Journal:  Nat Protoc       Date:  2011-09-08       Impact factor: 13.491

Review 3.  Metabonomics techniques and applications to pharmaceutical research & development.

Authors:  John C Lindon; Elaine Holmes; Jeremy K Nicholson
Journal:  Pharm Res       Date:  2006-05-25       Impact factor: 4.200

Review 4.  Application of metabonomic analytical techniques in the modernization and toxicology research of traditional Chinese medicine.

Authors:  Yong-Min Lao; Jian-Guo Jiang; Lu Yan
Journal:  Br J Pharmacol       Date:  2009-06-05       Impact factor: 8.739

Review 5.  Recent Trends in System-Scale Integrative Approaches for Discovering Protective Antigens Against Mycobacterial Pathogens.

Authors:  Aarti Rana; Shweta Thakur; Girish Kumar; Yusuf Akhter
Journal:  Front Genet       Date:  2018-11-27       Impact factor: 4.599

6.  Non-invasive nuclear magnetic resonance analysis of male and female embryo metabolites during in vitro embryo culture.

Authors:  Marcello Rubessa; Andrea Ambrosi; Dianelys Gonzalez-Pena; Kathryn M Polkoff; Matthew B Wheeler
Journal:  Metabolomics       Date:  2018-08-25       Impact factor: 4.290

7.  Is NMR metabolic profiling of spent embryo culture media useful to assist in vitro human embryo selection?

Authors:  Lydie Nadal-Desbarats; Ségolène Veau; Hélène Blasco; Patrick Emond; Dominique Royere; Christian R Andres; Fabrice Guérif
Journal:  MAGMA       Date:  2012-08-10       Impact factor: 2.310

8.  The Opportunities of Metabolomics in Drug Safety Evaluation.

Authors:  Pengcheng Wang; Amina I Shehu; Xiaochao Ma
Journal:  Curr Pharmacol Rep       Date:  2017-01-03

9.  Impact of prenatal stress on 1H NMR-based metabolic profiling of rat amniotic fluid.

Authors:  Sophie Serriere; Laurent Barantin; François Seguin; François Tranquart; Lydie Nadal-Desbarats
Journal:  MAGMA       Date:  2011-05-26       Impact factor: 2.310

10.  Biomarker discovery in animal health and disease: the application of post-genomic technologies.

Authors:  Rowan E Moore; Jennifer Kirwan; Mary K Doherty; Phillip D Whitfield
Journal:  Biomark Insights       Date:  2007-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.